Skip to Main Content

Try STAT+ TODAY

policy

Most Read

Politics Rachel Cohrs

STAT Plus: An unlikely new 340B alliance emerges between PhRMA and community health centers

Politics John Wilkerson

STAT Plus: Medicare chief on the new drug price negotiation program’s operations, hiring, and timelines

Politics Rachel Cohrs

STAT Plus: Biden proposes expanding Medicare drug negotiation program

Insurance Rachel Cohrs

STAT Plus: How can states keep people insured after Medicaid protections lapse? Connecticut has an idea

Politics John Wilkerson

STAT Plus: By cutting insulin prices, Eli Lilly avoids paying big Medicaid rebates

Health Nicholas Florko

STAT Plus: Cereal, pasta, and other food companies blast the FDA for a too-strict definition of ‘healthy’

Politics Rachel Cohrs and John Wilkerson

STAT Plus: Biden administration pitches 3 big new drug pricing reform experiments

Politics Nicholas Florko

STAT Plus: It’s easy to buy flavored vapes in California, even in cities with longtime bans

All Coverage

Politics John Wilkerson

STAT Plus: Would the federal government defer to states to regulate PBMs?

Politics Rachel Cohrs

STAT Plus: Biden administration to fine manufacturers of 27 medicines for price hikes

advertisement

Politics Joanne Silberner

STAT Plus: Medicare will take R&D costs, effectiveness into account when it negotiates drug prices. But studies show that doesn’t affect prices

Politics Rachel Cohrs

STAT Plus: Biden administration requests $20 billion cash infusion to bolster public health

Politics John Wilkerson

STAT Plus: Biden makes drug pricing a central part of his deficit reduction plans

Politics Nicholas Florko

STAT Plus: With an $11 billion price tag, the White House pitches a plan to end hepatitis C

Hospitals John Wilkerson

STAT Plus: Here’s another sign the Biden administration is taking a harsher stance on hospital consolidation

Insurance Bob Herman

STAT Plus: Medicare Advantage membership grows 7% for 2023

Politics John Wilkerson

STAT Plus: Republicans are using the FTC’s Lina Khan as an excuse for opposing drug pricing bills

Politics Sarah Owermohle

STAT Plus: Key Senate committee takes first step toward tackling health workforce shortages

In the Lab Andrew Joseph

Scientific institutions must embrace antiracist policies, National Academies report urges

Politics Rachel Cohrs

STAT Plus: Sen. Tammy Baldwin criticizes Ascension’s for-profit investment activities, requests returns and fees info

Politics Sarah Owermohle and John Wilkerson

STAT Plus: In State of the Union, Biden pitches addiction, mental health care policies as opportunities for bipartisanship

Politics Nicholas Florko

STAT Plus: After nearly 4 years of deliberation, FDA punts on how to regulate CBD

Politics Matthew Perrone — Associated Press

STAT Plus: New lawsuits target state restrictions on abortion pills

Politics John Wilkerson

STAT Plus: The 4 biggest questions about the FDA’s forthcoming changes to accelerated approvals

Politics Rachel Cohrs

STAT Plus: PhRMA terminates lobbying contract with White House official’s brother

Politics Sarah Owermohle

STAT Plus: ‘Hot mess’: Abortion pills at pharmacies could face legal quagmires, especially in restrictive states

Health Andrew Joseph

STAT Plus: Loan repayment program seeks to bolster infectious disease field

Insurance Bob Herman

STAT Plus: Oscar Health’s CEO on post-hype health insurance and finally turning a profit

Politics John Wilkerson

STAT Plus: With the FTC’s more expansive approach to antitrust, PBMs are in the crosshairs

Politics Rachel Cohrs

STAT Plus: HHS will seek more input on its new Medicare drug price negotiations

Politics Rachel Cohrs

Will America’s public health reckoning ever come?

Insurance Tara Bannow

STAT Plus: Insurers hint at suing Biden administration over plans for Medicare Advantage audits

Politics Sarah Owermohle

Still fuming over the federal Covid response, Republicans redirect the House coronavirus committee